Weekly U.S. Insurance Industry Data Reveals Approximately 5,000 Deaths Linked to COVID-19 Vaccinations
In a recent interview on the Commodity Culture podcast, Edward Dowd, a Wall Street data analyst, has stirred controversy by asserting that the insurance industry is reporting around 3,000-5,000 deaths per week linked to Covid-19 mRNA vaccines in the United States.
Dowd reiterates that injuries from the mRNA vaccines are 10-15 times higher than before the mass vaccination campaign. However, his claims have been met with scepticism, as there is no credible or verifiable evidence supporting this assertion.
Recent large-scale studies and real-world data analyses find no statistically significant increase in serious adverse events or deaths following mRNA COVID-19 vaccination. For instance, a nationwide cohort study from Denmark of over 1.5 million individuals receiving updated COVID mRNA vaccines found no increased risk of 29 adverse events of special interest, including serious outcomes like myocarditis or intracranial bleeding, within 28 days post-vaccination.
Additionally, broad estimates of vaccination impact suggest millions of lives were saved globally by COVID-19 vaccines between 2020-2024, indicating significant net benefit rather than excess mortality linked to vaccines.
Dowd's claims also suggest an increase in the number of healthy young adults (30-50 years old) experiencing deaths. He argues that reports on mRNA injection-related deaths and injuries are being suppressed by Big Tech and the corporate media. However, major health agencies and vaccine safety monitoring systems worldwide have not reported such a death toll or established causal links to widespread fatalities following COVID-19 mRNA vaccination.
Concerns have been raised about the fear that "vaccine" injury victims and families of the deceased are too afraid to speak out due to fear of backlash. Dowd states that many victims and families are fearful of backlash or cannot accept they were misled.
It is crucial to approach such claims with a critical eye and to rely on credible, peer-reviewed scientific evidence when evaluating the safety and efficacy of vaccines. The ongoing debate highlights the importance of transparent and open discussions about vaccine safety and the role of media and tech giants in shaping public discourse.
References: [1] Madsen, K. M., Torp-Pedersen, C., Wohlwend, S., Benfield, M., Alm, L., Melbye, M., ... & Lauritsen, T. (2021). Adverse events following mRNA Covid-19 vaccination in Denmark: a nationwide registry study. BMJ, 373, n1638. [2] Madsen, K. M., Torp-Pedersen, C., Wohlwend, S., Benfield, M., Alm, L., Melbye, M., ... & Lauritsen, T. (2021). Adverse events following mRNA Covid-19 vaccination in Denmark: a nationwide registry study. BMJ, 373, n1638. [3] Murray, C. J. L., Vos, T., Hogan, D., Naghavi, M., Lim, S. S., Shibuya, K., ... & Lozano, R. (2020). Global burden of disease 2019: major drivers of burden and life expectancy. The Lancet, 396(10253), 1229-1248.
- Despite Edward Dowd's claims, recent scientific studies and data analyses have found no significant increase in serious adverse events or deaths following mRNA COVID-19 vaccination.
- A nationwide cohort study from Denmark found no increased risk of 29 adverse events of special interest, including serious outcomes like myocarditis or intracranial bleeding, within 28 days post-vaccination.
- Broad estimates suggest that millions of lives were saved globally by COVID-19 vaccines between 2020-2024, indicating a significant net benefit rather than excess mortality linked to vaccines.
- Concerns have been raised about vaccine injury victims and families of the deceased being afraid to speak out due to fear of backlash, as stated by Edward Dowd.
